World Health Organization Sounds Warning Over Acute Scarcity of Obesity Jabs
Less than one in 10 people who could benefit from GLP-1 drugs such as Wegovy have access to them, states the global health agency as it issues its inaugural recommendations on the medications.
Given over a billion individuals worldwide currently classified as obese, it is advocating for increased and just availability to GLP-1 medication.
According to estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.
"Our new guidelines affirms that excess weight is a chronic disease that can be managed with thorough and continuous support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and supply-chain constraints are key hurdles to widespread availability to the injections that can aid individuals in losing substantial weight, says the body.
Skinny Jab Supply Crisis
Even in the present most optimistic scenario, the production of such drugs would only suffice for approximately 100 million people – less than 10% of eligible patients, per the health organization.
The guideline urges nations and manufacturers to increase access, via measures such as patent sharing.
Exclusive production rights on a key compound – the main ingredient of a leading brand – is due to expire in several countries in 2026.
How Obesity Injections Work
These medications mimick a body's own hormone to reduce digestion speed, reduce hunger and boost satiety so individuals reduce food intake.
Individuals usually see weight reduction in the initial weeks of commencing the once-weekly jabs.
Studies indicates users may regain a significant portion within a year of stopping the medication, as their usual appetite return.
To be carrying excess weight elevates your chance for contracting diseases, such as diabetes, cardiovascular issues, brain attack, and some cancers.
Excess weight concerns individuals in all nations and was responsible for 3.7 million deaths worldwide in 2024, per the WHO.
